Skip to main content

Published locations for ASCO: HR-deficient breast cancers more likely to respond to carboplatin

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. ASCO: HR-deficient breast cancers more likely to respond to carboplatin

User login

  • Reset your password
  • /content/asco-hr-deficient-breast-cancers-more-likely-respond-carboplatin
  • /oncologypractice/article/100529/breast-cancer/asco-hr-deficient-breast-cancers-more-likely-respond
  • /hematology-oncology/article/100529/breast-cancer/asco-hr-deficient-breast-cancers-more-likely
  • /breast-cancer-icymi/article/100529/breast-cancer/asco-hr-deficient-breast-cancers-more-likely